NorthWest Biotherapeutics Inc (NWBO)

[CogDiss 1188X]

Mav:

CLSN from $9500 to $1 a share

CogDiss:

This (still) doesn’t pass the smell test. If this chart were correct, then Celsion would have been worth $317 billion back in the day, more than 50% bigger than Merck now.

I suspect this is one of those bad data situations after multiple reverse splits.

In response, you post a link to the price history of CLSN that INCLUDES three reverse splints back to March of 1999 that shows the split-adjusted prices from $8 (not $9,500) to mere pennies zig-zagging like the polygraph test of a CDC bureaucrat answering questions on the safety and efficacy of the vaccine schedule.

Your last chart makes sense (peak price $8) but your earlier chart didn’t (peak price $9,500): the market cap back at the peak in 2000 was around $266 million, not $317 billion. The idea that a stock I never heard of had a market cap of $317 billion in 2000 didn’t make sense. That was the essence of my point.

Since you like the last laugh, feel free to take a parting pot shot if it suits you. I intend to refrain from replying as long as you swing above the belt.